84
criteria and have been recruited in the protocol. Of them, 164 participants exhibited
one out of eight sarcoma subtypes related with an intermediate prognosis and only 15
exhibited one out of two subtypes of the disease related to good prognosis. No patient
with a sarcoma subtype related to poor prognosis has been reported yet. Table 4.1
shows the available data.
Table 4.1: Reported number of successes∕trials for each one of the sarcoma subtypes.
Intermediate Prognosis
subtype successes∕trials
Leiomyosarcoma 6/28
Liposarcoma 7/29
MFH 3/29
Osteosarcoma 5/26
Synovial 3/20
Angiosarcoma 2/15
MPNST 1/5
Fibrosarcoma 1/12
Good Prognosis
Ewing’s 0/13
Rhabdo 0/2
4.3 Non-Exchangeable Product Partition Model
4.3.1 Model Definition
Let yi and N1 respectively denote the number of successes (i.e., patients with positive
outcome) and the total number of patients presenting with sarcoma subtype i, i =
More intriguing information
1. THE CO-EVOLUTION OF MATTER AND CONSCIOUSNESS12. Word Sense Disambiguation by Web Mining for Word Co-occurrence Probabilities
3. Innovation Trajectories in Honduras’ Coffee Value Chain. Public and Private Influence on the Use of New Knowledge and Technology among Coffee Growers
4. Asymmetric transfer of the dynamic motion aftereffect between first- and second-order cues and among different second-order cues
5. On s-additive robust representation of convex risk measures for unbounded financial positions in the presence of uncertainty about the market model
6. Benefits of travel time savings for freight transportation : beyond the costs
7. The mental map of Dutch entrepreneurs. Changes in the subjective rating of locations in the Netherlands, 1983-1993-2003
8. PROJECTED COSTS FOR SELECTED LOUISIANA VEGETABLE CROPS - 1997 SEASON
9. Sectoral specialisation in the EU a macroeconomic perspective
10. The name is absent